The $150 million was the advance payment for the at-risk manufacturing of those vaccines to guarantee Canadian access to doses from Medicago.
December 6th, 2023 / 7:05 p.m.
President, Public Health Agency of Canada
The $150 million was the advance payment for the at-risk manufacturing of those vaccines to guarantee Canadian access to doses from Medicago.
See context to find out what was said next.